In comparison, only 8 of 17 galectin-3-KO mice (47%) developed symptoms of ECM by day 8 post-infection, indicating that loss of galectin-3 conferred significant (p<0.0073, Fisher's exact test) protection from ECM. The gene discussed is LGALS3; the disease is infection.